UltraTech Cement Limited (ULTRACEMCO) fair value: what the stock is really worth
As of Nov 5, 2026: fair value (intrinsic value) of UltraTech Cement Limited stock ₹4,721, price ₹12,250, that is 61.5% below the price, quality 54 out of 100. Rating: strongly overvalued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with oneYes, for free
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 1, 2026.
How to read this chart
60‑month range ₹4,966 – ₹12,806 · fair‑value band ₹2,340 – ₹5,901 · the ₹12,250 price screens above the ₹4,721 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 1, 2026.
Follow UltraTech Cement in your weekly email
Every Wednesday you see whether UltraTech Cement is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
UltraTech Cement Limited, together with its subsidiaries, engages in the manufacture and sale of clinker, cement, ready mix concrete, and related products in India, the United Arab Emirates, Bahrain, and Sri Lanka.
Show moreShow less
The company offers ordinary Portland, Portland pozzolana, composite, Weather Plus, and Portland slag; white cement, wall care putty, and value-added products; ready-mix concrete; dry mix mortars, such as tile and marble binders, plasters and mortars, industrial and precision grouts, repair and rehabilitation, and flooring screed; and waterproofing products, including liquid and cement waterproofing products.
It also provides masonry products; and TMT steel bars, paints, waterproofing solutions and treatments, switchboards and fittings, plywood, shuttering ply, power and hand tools, PVC pipes, sanitary ware, roofing sheets, and water storage tanks, as well as flooring materials, such as marble, granite, and semi-precious stones through its retail stores under UltraTech Home Expert Store brand name.
In addition, the company operates mobile concrete labs that offers on-ground technical assessment of construction materials; and provides Vaastu, pest control, and water testing services, as well as home loans.
It offers its products under UltraTech Décor, DuraFacad, Pervious, MaxSheen, AquaSeal, ThermoCon+, FreeFlow+, FireSafe, DuraPlus, CorroProtect, Litecon, iFloors, Rapid, and ZIP brands. The company was incorporated in 2000 and is based in Mumbai, India.
UltraTech Cement Limited operates as a subsidiary of Grasim Industries Limited.
Stock analysis
UltraTech Cement Limited (ULTRACEMCO) currently trades at ₹12,250, while our model-based Fair Value estimate is ₹4,721, 61% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of ₹5,273 per share, and 0 of the 26 models we run sit above the ₹12,250 price.
Bear case: the Dividend Discount group reads lowest at ₹1,058, and 26 of the 26 models stay below the price. Data coverage for this calculation is high.
Scenario range: ₹2,340 (bear) to ₹5,901 (bull), the price of ₹12,250 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 54/100 (solid quality), in the Basic Materials sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
UltraTech Cement Limited reported revenue of ₹885B in FY2026 versus ₹526B in FY2022, a compound +13.9%/yr. Reported net income was ₹81.7B in FY2026, compounding +2.7%/yr from FY2022.
Key figures
Market cap ₹3.6T (≈ $38.2B) Large · P/E ratio 41.0 · P/S ratio 3.77 · EPS (TTM) ₹299.04 · Dividend yield 0.7% · Net margin 9.2% · Return on equity 11.5% · Return on assets (EBIT) 17.8%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 54 out of 100 (medium confidence).
What moves the price
The share trades about 4% below its 52-week high and 21% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Basic Materials peers we cover trades at −18% fair-value upside, at −61%, ULTRACEMCO screens richer than that median.
Fair Value models
Bear₹2,340Fair Value ₹4,721Bull₹5,901
Price ₹12,250 · Downside -61.5%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2026 figures (about 7 months old). Earnings retained since then (₹180.24 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.76/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+16.5%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+11.9%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+14.6%
Start year 2021 (pandemic). Over 10 years: +13.4% a year
Revenue growth 21 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+18.1%
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
’26
What shareholders gained per year (last 5 years), in INR ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in INR: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+7.5%
Earnings growth per share plus dividend.
Earnings per share, growth per year+6.8%
Dividend (yield on the price)0.7%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.6.8% vs 11.9%, slowing
Profit margin 2005 to 2026 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.5% → 14%
Pace: the 5-year rate starts in 2021 (pandemic)
Growth Forecast
A lot of optimism in the price
The price assumes more growth than the company has delivered so far and more than analysts expect.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+42.7%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+10.7%
Yearly sales growth analysts expect, extended to five years.
After inflation (India: IMF forecast 4.1% a year to 2030, 4.7% from 2016 to 2025) that is about +37.0% a year for the price and +6.3% for the forecasts.
Compare UltraTech Cement Limited with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Building Materials · 257 stocks
Beats the industry median on 6/15 measures
A mixed picture versus its industry peers.
Valuation
Quality Score54 · Above median
Fair Value upside−61.5% · Bottom 25%
Profitability
Return on equity (12 months)11.5% · Top 25%
Return on assets5.8% · Top 25%
Net margin (12 months)9.2% · Top 25%
Operating margin (12 months)10.8% · Above median
Growth and dividend
Revenue growth (quarter YoY)18.8% · Top 25%
Dividend yield (12 months)0.7% · Bottom 25%
Balance sheet
Debt / equity0.20× · Above median
Valuation Multiplesvs Building Materials median · lower = cheaper
P/E (12 months)41.0× · Priciest 25%
P/B4.71× · Priciest 25%
P/S (12 months)3.77× · Priciest 25%
Price / free cash flow92.9× · Priciest 25%
EV/EBITDA20.8× · Priciest 25%
PEG1.22× · Pricier than median
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 30
FUTURE (revenue growth)94· sector 12
PAST (return on equity)46· sector 18
HEALTH (low debt)90· sector 92
DIVIDEND (yield)14· sector 48
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Is UltraTech Cement Limited (ULTRACEMCO) overvalued or undervalued?
As of Nov 1, 2026, our model estimates a fair value of ₹4,721 versus a price of ₹12,250, about 61% lower (overvalued).
What is the fair value of ULTRACEMCO?
Our model-based fair value for UltraTech Cement Limited is ₹4,721 (as of Nov 1, 2026), built from audited fundamentals. The current price: ₹12,250.
What is the quality score of ULTRACEMCO?
UltraTech Cement Limited has a Quality Score of 54/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for UltraTech Cement Limited (ULTRACEMCO)?
Our model-based price target is the fair value of ₹4,721 (as of Nov 1, 2026) from 26 valuation models. Cautious scenario ₹2,340, optimistic scenario ₹5,901. It is a calculation from audited fundamentals, not an analyst target.
What is the UltraTech Cement Limited stock forecast for 2026?
Our models put fair value at ₹4,721, about 61% lower versus a price of ₹12,250 (overvalued). Cautious scenario ₹2,340, optimistic scenario ₹5,901. The calculation is refreshed regularly with new filings.
What is the revenue of UltraTech Cement Limited (ULTRACEMCO)?
UltraTech Cement Limited reported trailing-twelve-month revenue of about ₹956B (latest available figure, as of Nov 1, 2026).
Does UltraTech Cement Limited pay a dividend?
UltraTech Cement Limited currently shows a dividend yield of 0.71% relative to its recent price (as of Nov 1, 2026).
What growth is priced into UltraTech Cement Limited (ULTRACEMCO)?
For today's price to be fair in a discounted-cash-flow model, UltraTech Cement Limited would have to grow free cash flow by +42.7 % per year for five years (discount rate 10.4 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +14.6 % per year. As of Nov 1, 2026.
What discount rate (WACC) does the fair value of ULTRACEMCO use?
Our models discount UltraTech Cement Limited at 10.4 %: a base by market capitalisation (large), damped by beta 0.49, country premium for India. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For UltraTech Cement Limited that is +42.7 % per year a year over ten years, using the same discount rate (10.4 %) and the same formula as our fair value.
How much growth has UltraTech Cement Limited (ULTRACEMCO) delivered so far?
Over the past 5 years revenue at UltraTech Cement Limited grew +14.6 % a year. The price currently implies +42.7 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of UltraTech Cement Limited (ULTRACEMCO) growing?
The median revenue growth in the sector is +9.8 % a year. That is the yardstick for the growth priced into UltraTech Cement Limited (+42.7 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of UltraTech Cement Limited (ULTRACEMCO)?
The free-cash-flow yield on the price is 1.08 %: that much free cash flow UltraTech Cement Limited produces per unit of market value. When it exceeds the discount rate of our models (10.4 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of UltraTech Cement Limited (ULTRACEMCO)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For UltraTech Cement Limited it is ₹4,721 per share (as of Nov 1, 2026), against a price of ₹12,250. It is the blended result of 26 valuation models (cash flow, earnings, asset, dividend).
Is UltraTech Cement Limited stock overvalued or undervalued in 2026?
As of Nov 1, 2026, ULTRACEMCO trades above its calculated fair value: price ₹12,250, fair value ₹4,721, a gap of about −61% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of ULTRACEMCO?
No. The price is what the market pays today (₹12,250); the fair value is what the company's own numbers justify (₹4,721). For UltraTech Cement Limited the two are ₹7,529 per share apart. That gap is exactly why we show both numbers side by side.
How much is UltraTech Cement Limited worth?
The market values UltraTech Cement Limited at about ₹3.6T (market capitalisation, as of Nov 1, 2026). Per share that is ₹12,250; our models calculate a fair value of ₹4,721 per share.
What do the bullish and bearish scenarios say about ULTRACEMCO?
Our models span a range for UltraTech Cement Limited: cautious scenario ₹2,340, base ₹4,721, optimistic ₹5,901 per share (as of Nov 1, 2026, price ₹12,250). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of ULTRACEMCO?
UltraTech Cement Limited trades at a price-to-earnings ratio of 41.0 (as of Nov 1, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of ₹4,721 is built from several models across several years. Median P/E at fiscal year-end, 10 fiscal years (2017 to 2026), reported earnings, FY2026 ex one-offs: 40.1. Other multiples: PEG 1.2, P/B 4.7, P/S 3.8, EV/EBITDA 20.8.
What is the PEG ratio of ULTRACEMCO?
The PEG ratio of UltraTech Cement Limited is 1.22 (P/E divided by earnings growth, as of Nov 1, 2026). That is above 1, so the growth is already paid for in the price.
How solid is the balance sheet of UltraTech Cement Limited (ULTRACEMCO)?
Balance-sheet figures for UltraTech Cement Limited (as of Nov 1, 2026): return on equity 11.5%, debt of 0.20 per unit of equity. They feed the Quality Score of 54/100, which measures business quality independently of the share price.
How far is ULTRACEMCO from its 52-week high?
UltraTech Cement Limited trades at ₹12,250, about 4% below its 52-week high of ₹12,806 and 21% above the low of ₹10,143 (as of Nov 5, 2026). Distance from the high says nothing about value: that is what the fair value of ₹4,721 is for.
Which stocks are comparable to UltraTech Cement Limited?
From the same area (Basic Materials) we also value CRH plc, Holcim AG, Martin Marietta Materials, Inc, Vulcan Materials Company, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is UltraTech Cement Limited stock attractive at the current price?
The data as of Nov 1, 2026: price ₹12,250, calculated fair value ₹4,721 (−61%), Quality Score 54/100, from 26 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of ULTRACEMCO calculated?
We run UltraTech Cement Limited through 26 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of ₹4,721, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 15.5% above its aggregate fair value. UltraTech Cement Limited itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of UltraTech Cement Limited (ULTRACEMCO)?
The closing price on Nov 5, 2026 was ₹12,250. Our model-based fair value is ₹4,721, about 61% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with UltraTech Cement Limited right now?
The price sits above even our optimistic bull case (₹5,901). The favourable scenario is already priced in. Solid but not exceptional quality (54/100) and above fair value, neither a clear bargain nor a standout compounder. A fairly wide model range (₹2,340 to ₹5,901) leaves room in how you read the outcome.
Where does the earnings growth of UltraTech Cement Limited (ULTRACEMCO) come from?
Earnings per share at UltraTech Cement Limited grew +11.9 % a year from 2015 to 2026. Broken into its drivers: revenue per share +12.9 %, EBIT margin −3.2 %, tax rate +0.8 %, residual (interest, one-offs) +1.6 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.
Key figures of UltraTech Cement Limited
How large is the market capitalisation of UltraTech Cement Limited (ULTRACEMCO)?
The market capitalisation of UltraTech Cement Limited is ₹3.6T (≈ $38.2B). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of UltraTech Cement Limited (ULTRACEMCO)?
The price-to-sales ratio of UltraTech Cement Limited is 3.77 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of UltraTech Cement Limited (ULTRACEMCO)?
Earnings per share at UltraTech Cement Limited are ₹299.04 (price ÷ EPS = P/E 41.0). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of UltraTech Cement Limited (ULTRACEMCO)?
The dividend yield of UltraTech Cement Limited is 0.7% (payout 29.2%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of UltraTech Cement Limited (ULTRACEMCO)?
The net margin of UltraTech Cement Limited is 9.2% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of UltraTech Cement Limited (ULTRACEMCO)?
The return on equity (ROE) of UltraTech Cement Limited is 11.5% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of UltraTech Cement Limited (ULTRACEMCO)?
On an EBIT basis the return on assets of UltraTech Cement Limited is 17.8% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of UltraTech Cement Limited (ULTRACEMCO)?
The operating margin of UltraTech Cement Limited is 10.8% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at UltraTech Cement Limited (ULTRACEMCO)?
Revenue at UltraTech Cement Limited is growing +18.8% versus a year earlier (3y avg +11.9%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at UltraTech Cement Limited (ULTRACEMCO)?
Earnings per share at UltraTech Cement Limited are growing +21.3% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does UltraTech Cement Limited (ULTRACEMCO) carry?
The net debt of UltraTech Cement Limited is ₹224B (fiscal year 2026, ≈ 5.8 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch UltraTech Cement Limited in the live analysis
One click puts UltraTech Cement Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Broad data
Nov 1, 2026